Clinical [qlco]
Efficacy [qlco]
ibopamine [orch, phsu]
Heart failure [dsyn]
Result [ftcn]
Double-Blind Study [resa]
Clinical [qlco]
Efficacy [qlco]
weeks [tmco]
treatment [ftcn]
Evaluated [ftcn]
Patients [podg]
Males [fndg]
Females [fndg]
Mean [qnco]
Age-Years [tmco]
Chronic heart failure [dsyn]
Disability [fndg]
Defined [cnce]
New York Heart Association Classification [inpr]
Class I [clas]
Class II [inpr]
Class III [inpr]
Class IV [inpr]
Patients [podg]
Stable [qlco]
State [geoa]
Valvular heart disease [dsyn]
Arrhythmias, Cardiac [patf]
treatment [ftcn]
Recent myocardial infarction [fndg]
Trial [resa]
Commence [acty]
Control [grup]
Diuretic [phsu]
Furosemide [orch, phsu]
Alone [qnco]
Then [tmco]
Patients [podg]
Assigned [ftcn]
ibopamine [orch, phsu]
mg kg [qnco]
Three times daily [tmco]
placebo [topp]
Clinical status [qlco]
Evaluated [ftcn]
Control [grup]
weeks [tmco]
treatment [ftcn]
Diuretic [phsu]
Dosage [qnco]
Adjusted [ftcn]
Visit [bhvr]
Patients [podg]
Requirement [ftcn]
statistical analysis [resa]
included [ftcn]
Analysis [lbpr]
Variance [qlco]
ibopamine [orch, phsu]
placebo [topp]
Group [idcn]
Patients [podg]
Judge [prog]
To [qlco]
Treatment Failures [qlco]
Withdrawn [fndg]
Trial [resa]
P NOS [aapp, imft]
Clinical status [qlco]
Increased [qnco]
Group [idcn]
Furosemide [orch, phsu]
Dosage [qnco]
Reduced [qlco]
mg% [qnco]
Daily [tmco]
ibopamine [orch, phsu]
Group [idcn]
Compared [acty]
Increase [ftcn]
mg% [qnco]
Daily [tmco]
placebo [topp]
Group [idcn]
P NOS [aapp, imft]
ibopamine [orch, phsu]
APPEAR [qlco]
To [qlco]
possess [mobd]
Therapeutic [topp]
Benefits [qnco]
Patients [podg]
Mild [qlco]
Heart failure [dsyn]
PREVENT [phsu]
progression [patf]
Syndrome [dsyn]
